Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer

The purpose of this study was to determine whether epirubicin, cisplatin and infused 5FU (ECF) improves overall survival (OS) compared to 5FU, etoposide and leucovorin (FELV) in patients with previously untreated advanced biliary cancer in a prospective randomised study. Patients were randomly assig...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, S, Cunningham, D, Hawkins, R E, Hill, M E, Smith, D, Daniel, F, Ross, P J, Oates, J, Norman, A R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362051/
https://www.ncbi.nlm.nih.gov/pubmed/15856037
http://dx.doi.org/10.1038/sj.bjc.6602576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362051/
https://www.ncbi.nlm.nih.gov/pubmed/15856037
http://dx.doi.org/10.1038/sj.bjc.6602576

Ejemplares similares